Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels

Journal of Thoracic and Cardiovascular Surgery

Volumn 128, Issue 1, 2004, Pages 109-116

  Fortier, S ^a   Demaria, R G ^a,b   Lamarche, Y ^a   Malo, O ^a   Denault, A ^a   Desjardins, F ^a   Carrier, M ^a   Perrault, L P ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

25

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CYCLIC AMP; PHENYLEPHRINE; PROSTACYCLIN; PROSTAGLANDIN DERIVATIVE; VASODILATOR AGENT;

AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CARDIOPULMONARY BYPASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEATH; DRUG MECHANISM; ENDOTHELIUM LESION; FEMALE; HEART MUSCLE REPERFUSION; ISOLATED ARTERY; LUNG ARTERY; LUNG ARTERY PRESSURE; LUNG ENDOTHELIUM; MALE; NEBULIZATION; NONHUMAN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; STANDARDIZATION; STATISTICAL SIGNIFICANCE; SWINE; TEMPERATURE; TIME; VASODILATATION;

ACETYLCHOLINE; ADENOSINE MONOPHOSPHATE; ADMINISTRATION, INHALATION; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CARDIOVASCULAR AGENTS; CYCLIC AMP; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; INDOLES; LUNG; LUNG DISEASES; MALE; MODELS, CARDIOVASCULAR; PHENYLEPHRINE; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; SWINE; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 3042733578     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.09.056     Document Type: Article

References (29)

1. Kolff W.J., Effler D.B., Groves L.K., Hughes C.R., McCormack L.J. Pulmonary complications of open-heart operations their pathogenesis and avoidance. Cleve Clin Q. 25:1958;65-83
2. Ng C.S., Wan S., Yim A.P., Arifi A.A. Pulmonary dysfunction after cardiac surgery. Chest. 121:2002;1269-1277
3. Wan S., LeClerc J.L., Vincent J.L. Inflammatory response to cardiopulmonary bypass mechanisms involved and possible therapeutic strategies. Chest. 112:1997;676-692
4. Boyle E.M. Jr, Pohlman T.H., Johnson M.C., Verrier E.D. Endothelial cell injury in cardiovascular surgery the systemic inflammatory response. Ann Thorac Surg. 63:1997;277-284
5. Higenbottam T.W., Laude E.A. Endothelial dysfunction providing the basis for the treatment of pulmonary hypertension Giles F. Filley lecture. Chest. 114:1998;72S-79S
6. Chen Y.F., Oparil S. Endothelial dysfunction in the pulmonary vascular bed. Am J Med Sci. 320:2000;223-232
7. Scheeren T., Radermacher P. Prostacyclin (PGI2) new aspects of an old substance in the treatment of critically ill patients. Intensive Care Med. 23:1997;146-158
8. Haché M., Denault A.Y., Belisle S., Couture P., Babin D., Tetrault F., et al. Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit. Can J Anaesth. 48:2001;924-929
9. Max M., Rossaint R. Inhaled prostacyclin in the treatment of pulmonary hypertension. Eur J Pediatr. 158:(Suppl 1):1999;S23-26
10. Gagnon J., Desjardins N., Malo O., Carrier M., Perrault L.P. Mechanism of pulmonary artery endothelial dysfunction secondary to cardiopulmonary bypass. Canadian Perfusion. 11:2001;8-16
11. Carr J.A., Silverman N. The heparin-protamine interaction. A review. J Cardiovasc Surg (Torino). 40:1999;659-666
12. Haché M., Denault A.Y., Belisle S., Robitaille D., Couture P., Sheridan P., et al. Inhaled prostacyclin and pulmonary hypertension in cardiac surgery. J Thorac Cardiovasc Surg. 125:2003;642-649
13. Riedel B. The pathophysiology and management of perioperative pulmonary hypertension with specific emphasis on the period following cardiac surgery. Int Anesthesiol Clin. 37:1999;55-79
14. Morita K., Ihnken K., Buckberg G.D., Sherman M.P., Ignarro L.J. Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass. Ann Thorac Surg. 61:1996;1775-1780
15. Davila-Roman V.G., Waggoner A.D., Hopkins W.E., Barzilai B. Right ventricular dysfunction in low output syndrome after cardiac operations assessment by transesophageal echocardiography. Ann Thorac Surg. 60:1995;1081-1086
16. Maslow A.D., Regan M.M., Panzica P., Heindel S., Mashikian J., Comunale M.E. Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction. Anesth Analg. 95:2002;1507-1518
17. Downing S.W., Edmunds L.H. Jr. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 54:1992;1236-1243
18. Schwinn D.A., McIntyre R.W., Hawkins E.D., Kates R.A., Reves J.G. Alpha 1-adrenergic responsiveness during coronary artery bypass surgery effect of preoperative ejection fraction. Anesthesiology. 69:1988;206-217
19. Wachtogel Y.T., Musial J., Jenkin B., Niewiarowski S., Edmunds L.H. Jr, Colman R.W. Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation prevention with prostaglandin E1. J Lab Clin Med. 105:1985;601-607
20. McMullan D.M., Bekker J.M., Parry A.J., Johengen M.J., Kon A., Heidersbach R.S., et al. Alterations in endogenous nitric oxide production after cardiopulmonary bypass in lambs with normal and increased pulmonary blood flow. Circulation. 102:(Suppl 3):2000;III172-178
21. Liu S.F., Barnes P.J. Role of endothelium in the control of pulmonary vascular tone. Endothelium. 2:1994;11-33
22. Zanaboni P., Murray P.A., Simon B.A., Zehr K., Fleischer K., Tseng E., et al. Selective endothelial dysfunction in conscious dogs after cardiopulmonary bypass. J Appl Physiol. 82:1997;1776-1784
23. Kamper A.M., Paul L.C., Blauw G.J. Prostaglandins are involved in acetylcholine- and 5-hydroxytryptamine-induced, nitric oxide-mediated vasodilatation in human forearm. J Cardiovasc Pharmacol. 40:2002;922-929
24. Zhang X., Hintze T.H. cAMP signal transduction cascade, a novel pathway for the regulation of endothelial nitric oxide production in coronary blood vessels. Arterioscler Thromb Vasc Biol. 21:2001;797-803
25. Weston M.W., Isaac B.F., Crain C. The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension. J Heart Lung Transplant. 20:2001;1340-1344
26. Haraldsson A., Kieler-Jensen N., Wadenvik H., Ricksten S.E. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass. Intensive Care Med. 26:2000;188-194
27. Magnusson L., Zemgulis V., Wicky S., Tyden H., Hedenstierna G. Effect of CPAP during cardiopulmonary bypass on postoperative lung function. An experimental study. Acta Anaesthesiol Scand. 42:1998;1133-1138
28. Kleen M., Habler O., Hofstetter C., Pusch R., Mueller M., Welte M., Zwissler B. Efficacy of inhaled prostanoids in experimental pulmonary hypertension. Crit Care Med. 26:1998;1103-1109
29. 2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs. Intensive Care Med. 22:1996;426-433